Low dose novel PARP-PI3K inhibition via nanoformulation improves colorectal cancer immunoradiotherapy

M. R. Landry, A. N. DuRoss, M. J. Neufeld, L. Hahn, G. Sahay, R. Luxenhofer, C. Sun

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number100082
JournalMaterials today bio
Volume8
Number of pages13
ISSN2590-0064
DOIs
Publication statusPublished - Sept 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Radiation therapy
  • Immune checkpoint blockade
  • Poly(2-oxazoline)
  • Nanomedicine
  • Drug delivery
  • PI3K INHIBITOR
  • DNA-DAMAGE
  • HS-173
  • TUMORS
  • RADIOSENSITIZATION
  • IMMUNOTHERAPY
  • COMBINATION
  • EXPOSURE
  • REPAIR
  • CELLS
  • 116 Chemical sciences
  • 114 Physical sciences
  • 1182 Biochemistry, cell and molecular biology

Cite this